Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma

Recruiting now · Not applicable

Conditions studied: Siewert Type II Adenocarcinoma of Esophagogastric Junction

In brief

To explore the 5-year overall survival (OS) of right versus left thoracic surgical approaches for patients with locally advanced Siewert II gastroesophageal junction adenocarcinoma treated by neoadjuvant chemotherapy

Key facts

Study ID
NCT06644352
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
People needed
236
Starts
2022-07-01
Expected to finish
2027-07-01
Last updated by the study team
2024-10-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.